![Deepak Sapra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 M $ in data 31/05/2026
Deepak Sapra is currently the Chief Executive Officer-API & Services at Dr. Reddy's Laboratories Ltd. since 2003.
He is also a Director at Aurigene Pharmaceutical Services Ltd. Mr. Sapra was previously the Head-Custom Pharma Services Unit at Indian Institute of Management Bangalore.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/12/2025 | 75.624 ( 0,01% ) | 1 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Corporate Officer/Principal | 01/01/2003 |
Aurigene Pharmaceutical Services Ltd.
 Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Engages in research and development of novel therapeutics for the treatment of cancer and inflammation | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Indian Institute of Management Bangalore
 Indian Institute of Management Bangalore Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Dr. Reddy's Laboratories Ltd.
 Dr. Reddy's Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Indian Institute of Management Bangalore
Indian Institute of Management Bangalore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurigene Pharmaceutical Services Ltd.
Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Engages in research and development of novel therapeutics for the treatment of cancer and inflammation | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
